Lateral Flow Assays Market by Product (Kits, Readers), Application (HIV, HPV, TB, Cardiac Marker, Pregnancy, Hepatitis, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), Region - Global Forecast to 2031
The lateral flow assays market is expected to grow from USD 9.14 billion in 2026 to USD 13.52 billion by 2031, with a CAGR of 8.1%. The high prevalence of infectious diseases worldwide and the resulting need for testing, rapid growth in the geriatric population, the rising use of home-based lateral flow assay devices, and growing demand for POC testing are the major factors driving market growth. However, inconsistent accuracy compared to other methods and reluctance among doctors and patients to shift from traditional diagnostics are restraining growth in the lateral flow assays market.
A breakdown of the primary participants referred to in this report is provided below:
“The clinical testing segment, by application, is expected to hold the largest share during the forecast period.”
The clinical testing segment is the largest application segment in the lateral flow assays market. By application, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2025. This segment's large share is attributed to the rising prevalence of chronic and infectious diseases worldwide, the growing geriatric population, increasing patient awareness of rapid test options, growing pressure to reduce healthcare costs, and increasing demand for patient-centric care.“The hospitals & clinics segment accounts for the largest market share in the lateral flow assays market.”
Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. Hospitals & clinics accounted for the largest market share in 2025. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast, early diagnosis are driving growth in the hospitals & clinics segment.“North America is expected to hold the largest share during the forecast period.”
The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America leads this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period.A breakdown of the primary participants referred to in this report is provided below:
- By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
- By Designation: C-level: 27%, Director Level: 18%, and Others: 55%
- By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4%
- The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioM?rieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), SurModics, Inc. (US), and OraSure Technologies, Inc. (US).
Research Coverage
This report studies the lateral flow assays market based on product (kits & reagents and readers), application (clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing), technique (sandwich assays, competitive assays, and multiplex detection assays), sample type (blood samples, urine samples, saliva samples, and other samples), end user (hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries). The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by their individual growth trends. It forecasts revenue for the market segments across six major regions (and the respective countries in these regions).Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.The report provides insights on the following points
- Analysis of key drivers (high prevalence of infectious diseases, rising geriatric population, growing use of home-based lateral flow assay devices, and growing demand for POC testing), restraints (inconsistent results of lateral flow assay tests), opportunities (evolving applications of lateral flow assays and rising demand for lateral flow assays in the food & beverage industry), and challenges (limited reimbursements for lateral flow assay products and difficulties in procuring quality raw materials to develop tests)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lateral flow assays market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the lateral flow assays market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lateral flow assays market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
3.2 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2026 VS. 2031
3.3 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2026 VS. 2031
3.4 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2026 VS. 2031
3.5 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2026 VS. 2031
3.6 LATERAL FLOW ASSAYS MARKET, BY END USER, 2026 VS. 2031
3.7 LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 High prevalence of infectious diseases
4.2.1.2 Rising geriatric population
4.2.1.3 Growing use of home-based lateral flow assay devices
4.2.1.4 Growing demand for point-of-care (POC) testing
4.2.2 RESTRAINTS
4.2.2.1 Inconsistent results of lateral flow assay tests
4.2.3 OPPORTUNITIES
4.2.3.1 Evolving applications of lateral flow assays
4.2.3.2 Rising demand for lateral flow assays in food & beverage industry
4.2.4 CHALLENGES
4.2.4.1 Limited reimbursements for lateral flow assay products
4.2.4.2 Difficulties in procuring quality raw materials to develop tests
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN LATERAL FLOW ASSAYS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE, BY REGION, 2024–2026
5.6.2 AVERAGE SELLING PRICE, BY KEY PLAYER, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 382200)
5.7.2 EXPORT SCENARIO (HS CODE 382200)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 IMPACT OF 2025 US TARIFFS–LATERAL FLOW ASSAYS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRIES/REGIONS
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Hospitals & clinics
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 IMMUNOCHROMATOGRAPHY
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 LYOPHILIZATION (FREEZE-DRYING) TECHNOLOGIES
6.3 ADJACENT TECHNOLOGIES
6.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 LIST OF MAJOR PATENTS
6.6 FUTURE APPLICATIONS
6.7 IMPACT OF AI/GENERATIVE AI ON LATERAL FLOW ASSAYS MARKET
6.7.1 INTRODUCTION
6.7.2 TOP USE CASES AND MARKET POTENTIAL
6.7.3 KEY COMPANIES IMPLEMENTING AI
6.7.4 FUTURE OF AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 India
7.1.1.3.2 China
7.1.1.3.3 Japan
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Rest of the world
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN LATERAL FLOW ASSAYS MARKET
7.2.1.1 Eco-friendly Initiatives
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 KITS & REAGENTS
9.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET
9.3 READERS
9.3.1 DIGITAL/HANDHELD READERS
9.3.1.1 Technological evolutions and demand for accuracy to drive adoption
9.3.2 BENCHTOP READERS
9.3.2.1 Lower diagnosis cost per patient to drive adoption
10 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE
10.1 INTRODUCTION
10.2 SANDWICH ASSAYS
10.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
10.3 COMPETITIVE ASSAYS
10.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
10.4 MULTIPLEX DETECTION ASSAYS
10.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET
11 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 CLINICAL TESTING
11.2.1 INFECTIOUS DISEASE TESTING
11.2.1.1 Mosquito-borne diseases
11.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market
11.2.1.2 Influenza
11.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays
11.2.1.3 Sexually transmitted infections
11.2.1.3.1 HIV
11.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market
11.2.1.3.2 HPV
11.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering a broad range of genotypes, coupled with the higher incidence of cervical cancer to drive segment
11.2.1.3.3 Chlamydia
11.2.1.3.3.1 Greater viability of advanced techniques to drive market
11.2.1.3.4 Gonorrhea
11.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth
11.2.1.3.5 Syphilis
11.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth
11.2.1.3.6 Other sexually transmitted infections
11.2.1.4 Hepatitis
11.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
11.2.1.5 Tuberculosis
11.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market
11.2.1.6 Other infectious diseases
11.2.2 CARDIAC MARKER TESTING
11.2.2.1 Troponin I & T
11.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth
11.2.2.2 CK-MB
11.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
11.2.2.3 BNP & NT-proBNP
11.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth
11.2.2.4 Myoglobin
11.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
11.2.2.5 D-Dimer
11.2.2.5.1 Rising incidence of CVDs to drive market for D-Dimer tests
11.2.2.6 Other cardiac markers
11.2.3 PREGNANCY & FERTILITY TESTING
11.2.3.1 Pregnancy testing
11.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
11.2.3.2 Fertility testing
11.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits
11.2.4 CHOLESTEROL/LIPID TESTING
11.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment
11.2.5 DRUGS-OF-ABUSE TESTING
11.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
11.2.6 OTHER CLINICAL TESTS
11.3 VETERINARY DIAGNOSTICS
11.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET
11.4 FOOD SAFETY & ENVIRONMENT TESTING
11.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY
11.5 DRUG DEVELOPMENT & QUALITY TESTING
11.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
12 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE
12.1 INTRODUCTION
12.2 BLOOD SAMPLES
12.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
12.3 URINE SAMPLES
12.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS- OF-ABUSE TESTING TO DRIVE MARKET
12.4 SALIVA SAMPLES
12.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
12.5 OTHER SAMPLES
13 LATERAL FLOW ASSAYS MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS & CLINICS
13.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET
13.3 HOME CARE SETTINGS
13.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
13.4 DIAGNOSTIC LABORATORIES
13.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
13.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5.1 RISING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
13.6 OTHER END USERS
14 LATERAL FLOW ASSAYS MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Large patient base to drive market growth
14.2.2 CANADA
14.2.2.1 Availability of research funding and implementation of favorable government initiatives to drive market
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Well-developed healthcare system and rise in geriatric population to fuel growth
14.3.2 UK
14.3.2.1 Growth in incidence of chronic conditions to propel market growth
14.3.3 FRANCE
14.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
14.3.4 ITALY
14.3.4.1 Growth in initiatives toward decentralization of medical services to support market growth
14.3.5 SPAIN
14.3.5.1 Aging population and strong healthcare infrastructure to drive market
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 JAPAN
14.4.1.1 Growing elderly population and well-developed healthcare system to drive market
14.4.2 CHINA
14.4.2.1 Modernized healthcare system to drive market
14.4.3 INDIA
14.4.3.1 Growth in healthcare concerns and rise in income levels to propel market growth
14.4.4 AUSTRALIA
14.4.4.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth
14.4.5 SOUTH KOREA
14.4.5.1 Growth in healthcare infrastructure to drive market
14.4.6 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 BRAZIL
14.5.1.1 High private healthcare expenditure and rise in geriatric population to drive market
14.5.2 MEXICO
14.5.2.1 Efficient healthcare system and universal health coverage to support adoption
14.5.3 ARGENTINA
14.5.3.1 Availability of health insurance to favor market growth
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 RISING BURDEN OF INFECTIOUS DISEASES AND GROWING GOVERNMENT SUPPORT TO DRIVE MARKET
14.7 GCC COUNTRIES
14.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET
15 LATERAL FLOW ASSAYS MARKET: VOLUME ANALYSIS
15.1 INTRODUCTION
15.2 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2024–2031 (MILLION)
16 COMPETITIVE LANDSCAPE
16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
16.3 REVENUE ANALYSIS, 2023–2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 COMPANY VALUATION AND FINANCIAL METRICS
16.6 BRAND/PRODUCT COMPARISON
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.7.1 STARS
16.7.2 EMERGING LEADERS
16.7.3 PERVASIVE PLAYERS
16.7.4 PARTICIPANTS
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1 Company footprint
16.7.5.2 Region footprint
16.7.5.3 Product footprint
16.7.5.4 Technique footprint
16.7.5.5 Application footprint
16.7.5.6 Sample type footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1 PROGRESSIVE COMPANIES
16.8.2 RESPONSIVE COMPANIES
16.8.3 DYNAMIC COMPANIES
16.8.4 STARTING BLOCKS
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1 Detailed list of key startup/SME players
16.8.5.2 Competitive benchmarking of key startups/SMEs
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES & APPROVALS
16.9.2 DEALS
17 COMPANY PROFILES
17.1 KEY PLAYERS
17.1.1 ABBOTT LABORATORIES
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Product launches & approvals
17.1.1.4 MnM view
17.1.1.4.1 Right to win
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 F. HOFFMANN-LA ROCHE LTD.
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Deals
17.1.2.4 MnM view
17.1.2.4.1 Right to win
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 DANAHER CORPORATION
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 Recent developments
17.1.3.3.1 Deals
17.1.3.4 MnM view
17.1.3.4.1 Right to win
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 QUIDELORTHO CORPORATION
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Product launches
17.1.5 SIEMENS AG
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.6 BECTON, DICKINSON AND COMPANY
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.6.3 Recent developments
17.1.6.3.1 Product approvals
17.1.7 BIOM?RIEUX SA
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.7.3 Recent developments
17.1.7.3.1 Deals
17.1.8 THERMO FISHER SCIENTIFIC INC.
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.9 REVVITY, INC.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.10 QIAGEN N.V.
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.11 MERCK KGAA
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.12 HOLOGIC, INC.
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Deals
17.1.13 SURMODICS, INC.
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.1.14 ORASURE TECHNOLOGIES, INC.
17.1.14.1 Business overview
17.1.14.2 Products offered
17.1.14.3 Recent developments
17.1.14.3.1 Product launches & approvals
17.1.14.3.2 Deals
17.2 OTHER PLAYERS
17.2.1 CHEMBIO DIAGNOSTICS, INC.
17.2.2 DCN DIAGNOSTICS
17.2.3 POLYSCIENCES INC.
17.2.4 ABINGDON HEALTH
17.2.5 ORANOXIS INC.
17.2.6 AESKU.GROUP GMBH
17.2.7 BIO GROUP MEDICAL SYSTEM S.R.L.
17.2.8 PHARMACT GMBH
17.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
17.2.10 BIOPANDA REAGENTS LTD
17.2.11 ARTRON LABORATORIES INC.
18 RESEARCH METHODOLOGY
18.1 RESEARCH DATA
18.1.1 SECONDARY DATA
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY DATA
18.1.2.1 Primary sources
18.1.2.2 Key industry insights
18.1.2.3 Key data from primary sources
18.1.2.4 Breakdown of primary interviews
18.2 MARKET SIZE ESTIMATION
18.2.1 BOTTOM-UP APPROACH
18.2.1.1 Approach 1: Company revenue estimation approach
18.2.1.2 Approach 2: Presentations of companies and primary interviews
18.2.1.3 Approach 3: Primary interviews
18.2.1.4 Approach 4: Growth Forecast
18.2.1.5 CAGR projections
18.2.2 TOP-DOWN APPROACH
18.3 MARKET BREAKDOWN & DATA TRIANGULATION
18.4 RESEARCH ASSUMPTIONS
18.4.1 STUDY-RELATED ASSUMPTIONS
18.4.2 GROWTH RATE ASSUMPTIONS
18.5 RISK ASSESSMENT
18.6 RESEARCH LIMITATIONS
19 APPENDIX
19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
3.2 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2026 VS. 2031
3.3 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2026 VS. 2031
3.4 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2026 VS. 2031
3.5 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2026 VS. 2031
3.6 LATERAL FLOW ASSAYS MARKET, BY END USER, 2026 VS. 2031
3.7 LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 High prevalence of infectious diseases
4.2.1.2 Rising geriatric population
4.2.1.3 Growing use of home-based lateral flow assay devices
4.2.1.4 Growing demand for point-of-care (POC) testing
4.2.2 RESTRAINTS
4.2.2.1 Inconsistent results of lateral flow assay tests
4.2.3 OPPORTUNITIES
4.2.3.1 Evolving applications of lateral flow assays
4.2.3.2 Rising demand for lateral flow assays in food & beverage industry
4.2.4 CHALLENGES
4.2.4.1 Limited reimbursements for lateral flow assay products
4.2.4.2 Difficulties in procuring quality raw materials to develop tests
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN LATERAL FLOW ASSAYS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF NEW ENTRANTS
5.1.4 THREAT OF SUBSTITUTES
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE, BY REGION, 2024–2026
5.6.2 AVERAGE SELLING PRICE, BY KEY PLAYER, 2024–2026
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 382200)
5.7.2 EXPORT SCENARIO (HS CODE 382200)
5.8 KEY CONFERENCES & EVENTS, 2026–2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT & FUNDING SCENARIO
5.11 IMPACT OF 2025 US TARIFFS–LATERAL FLOW ASSAYS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRIES/REGIONS
5.11.4.1 North America
5.11.4.2 Europe
5.11.4.3 Asia Pacific
5.11.5 IMPACT ON END-USE INDUSTRIES
5.11.5.1 Hospitals & clinics
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 IMMUNOCHROMATOGRAPHY
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 LYOPHILIZATION (FREEZE-DRYING) TECHNOLOGIES
6.3 ADJACENT TECHNOLOGIES
6.3.1 ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 LIST OF MAJOR PATENTS
6.6 FUTURE APPLICATIONS
6.7 IMPACT OF AI/GENERATIVE AI ON LATERAL FLOW ASSAYS MARKET
6.7.1 INTRODUCTION
6.7.2 TOP USE CASES AND MARKET POTENTIAL
6.7.3 KEY COMPANIES IMPLEMENTING AI
6.7.4 FUTURE OF AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.1.1 North America
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 India
7.1.1.3.2 China
7.1.1.3.3 Japan
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Rest of the world
7.2 SUSTAINABILITY INITIATIVES
7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN LATERAL FLOW ASSAYS MARKET
7.2.1.1 Eco-friendly Initiatives
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9 LATERAL FLOW ASSAYS MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 KITS & REAGENTS
9.2.1 RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET
9.3 READERS
9.3.1 DIGITAL/HANDHELD READERS
9.3.1.1 Technological evolutions and demand for accuracy to drive adoption
9.3.2 BENCHTOP READERS
9.3.2.1 Lower diagnosis cost per patient to drive adoption
10 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE
10.1 INTRODUCTION
10.2 SANDWICH ASSAYS
10.2.1 WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH
10.3 COMPETITIVE ASSAYS
10.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH
10.4 MULTIPLEX DETECTION ASSAYS
10.4.1 HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET
11 LATERAL FLOW ASSAYS MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 CLINICAL TESTING
11.2.1 INFECTIOUS DISEASE TESTING
11.2.1.1 Mosquito-borne diseases
11.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market
11.2.1.2 Influenza
11.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays
11.2.1.3 Sexually transmitted infections
11.2.1.3.1 HIV
11.2.1.3.1.1 Growing need for early detection and awareness of HIV POC testing to drive market
11.2.1.3.2 HPV
11.2.1.3.2.1 Rapid HPV diagnostics and real-time PCR, covering a broad range of genotypes, coupled with the higher incidence of cervical cancer to drive segment
11.2.1.3.3 Chlamydia
11.2.1.3.3.1 Greater viability of advanced techniques to drive market
11.2.1.3.4 Gonorrhea
11.2.1.3.4.1 Rising incidence of gonorrhea and antimicrobial resistance to augment growth
11.2.1.3.5 Syphilis
11.2.1.3.5.1 Need for early and accessible diagnosis to fuel growth
11.2.1.3.6 Other sexually transmitted infections
11.2.1.4 Hepatitis
11.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing
11.2.1.5 Tuberculosis
11.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market
11.2.1.6 Other infectious diseases
11.2.2 CARDIAC MARKER TESTING
11.2.2.1 Troponin I & T
11.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth
11.2.2.2 CK-MB
11.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market
11.2.2.3 BNP & NT-proBNP
11.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth
11.2.2.4 Myoglobin
11.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth
11.2.2.5 D-Dimer
11.2.2.5.1 Rising incidence of CVDs to drive market for D-Dimer tests
11.2.2.6 Other cardiac markers
11.2.3 PREGNANCY & FERTILITY TESTING
11.2.3.1 Pregnancy testing
11.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth
11.2.3.2 Fertility testing
11.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits
11.2.4 CHOLESTEROL/LIPID TESTING
11.2.4.1 Lifestyle changes, cardiovascular disorder incidence to drive segment
11.2.5 DRUGS-OF-ABUSE TESTING
11.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market
11.2.6 OTHER CLINICAL TESTS
11.3 VETERINARY DIAGNOSTICS
11.3.1 INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET
11.4 FOOD SAFETY & ENVIRONMENT TESTING
11.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY
11.5 DRUG DEVELOPMENT & QUALITY TESTING
11.5.1 GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH
12 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE
12.1 INTRODUCTION
12.2 BLOOD SAMPLES
12.2.1 SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET
12.3 URINE SAMPLES
12.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS- OF-ABUSE TESTING TO DRIVE MARKET
12.4 SALIVA SAMPLES
12.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION
12.5 OTHER SAMPLES
13 LATERAL FLOW ASSAYS MARKET, BY END USER
13.1 INTRODUCTION
13.2 HOSPITALS & CLINICS
13.2.1 HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET
13.3 HOME CARE SETTINGS
13.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET
13.4 DIAGNOSTIC LABORATORIES
13.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING
13.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.5.1 RISING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS
13.6 OTHER END USERS
14 LATERAL FLOW ASSAYS MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 Large patient base to drive market growth
14.2.2 CANADA
14.2.2.1 Availability of research funding and implementation of favorable government initiatives to drive market
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Well-developed healthcare system and rise in geriatric population to fuel growth
14.3.2 UK
14.3.2.1 Growth in incidence of chronic conditions to propel market growth
14.3.3 FRANCE
14.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market
14.3.4 ITALY
14.3.4.1 Growth in initiatives toward decentralization of medical services to support market growth
14.3.5 SPAIN
14.3.5.1 Aging population and strong healthcare infrastructure to drive market
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 JAPAN
14.4.1.1 Growing elderly population and well-developed healthcare system to drive market
14.4.2 CHINA
14.4.2.1 Modernized healthcare system to drive market
14.4.3 INDIA
14.4.3.1 Growth in healthcare concerns and rise in income levels to propel market growth
14.4.4 AUSTRALIA
14.4.4.1 Rise in prevalence of infectious disease and healthcare expenditure to support growth
14.4.5 SOUTH KOREA
14.4.5.1 Growth in healthcare infrastructure to drive market
14.4.6 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 BRAZIL
14.5.1.1 High private healthcare expenditure and rise in geriatric population to drive market
14.5.2 MEXICO
14.5.2.1 Efficient healthcare system and universal health coverage to support adoption
14.5.3 ARGENTINA
14.5.3.1 Availability of health insurance to favor market growth
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 RISING BURDEN OF INFECTIOUS DISEASES AND GROWING GOVERNMENT SUPPORT TO DRIVE MARKET
14.7 GCC COUNTRIES
14.7.1 RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS TO DRIVE MARKET
15 LATERAL FLOW ASSAYS MARKET: VOLUME ANALYSIS
15.1 INTRODUCTION
15.2 GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2024–2031 (MILLION)
16 COMPETITIVE LANDSCAPE
16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET
16.3 REVENUE ANALYSIS, 2023–2025
16.4 MARKET SHARE ANALYSIS, 2025
16.5 COMPANY VALUATION AND FINANCIAL METRICS
16.6 BRAND/PRODUCT COMPARISON
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
16.7.1 STARS
16.7.2 EMERGING LEADERS
16.7.3 PERVASIVE PLAYERS
16.7.4 PARTICIPANTS
16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1 Company footprint
16.7.5.2 Region footprint
16.7.5.3 Product footprint
16.7.5.4 Technique footprint
16.7.5.5 Application footprint
16.7.5.6 Sample type footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1 PROGRESSIVE COMPANIES
16.8.2 RESPONSIVE COMPANIES
16.8.3 DYNAMIC COMPANIES
16.8.4 STARTING BLOCKS
16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1 Detailed list of key startup/SME players
16.8.5.2 Competitive benchmarking of key startups/SMEs
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES & APPROVALS
16.9.2 DEALS
17 COMPANY PROFILES
17.1 KEY PLAYERS
17.1.1 ABBOTT LABORATORIES
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Product launches & approvals
17.1.1.4 MnM view
17.1.1.4.1 Right to win
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses and competitive threats
17.1.2 F. HOFFMANN-LA ROCHE LTD.
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Deals
17.1.2.4 MnM view
17.1.2.4.1 Right to win
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses and competitive threats
17.1.3 DANAHER CORPORATION
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 Recent developments
17.1.3.3.1 Deals
17.1.3.4 MnM view
17.1.3.4.1 Right to win
17.1.3.4.2 Strategic choices
17.1.3.4.3 Weaknesses and competitive threats
17.1.4 QUIDELORTHO CORPORATION
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Product launches
17.1.5 SIEMENS AG
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.6 BECTON, DICKINSON AND COMPANY
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.6.3 Recent developments
17.1.6.3.1 Product approvals
17.1.7 BIOM?RIEUX SA
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.7.3 Recent developments
17.1.7.3.1 Deals
17.1.8 THERMO FISHER SCIENTIFIC INC.
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.9 REVVITY, INC.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.10 QIAGEN N.V.
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.11 MERCK KGAA
17.1.11.1 Business overview
17.1.11.2 Products offered
17.1.12 HOLOGIC, INC.
17.1.12.1 Business overview
17.1.12.2 Products offered
17.1.12.3 Recent developments
17.1.12.3.1 Deals
17.1.13 SURMODICS, INC.
17.1.13.1 Business overview
17.1.13.2 Products offered
17.1.13.3 Recent developments
17.1.13.3.1 Deals
17.1.14 ORASURE TECHNOLOGIES, INC.
17.1.14.1 Business overview
17.1.14.2 Products offered
17.1.14.3 Recent developments
17.1.14.3.1 Product launches & approvals
17.1.14.3.2 Deals
17.2 OTHER PLAYERS
17.2.1 CHEMBIO DIAGNOSTICS, INC.
17.2.2 DCN DIAGNOSTICS
17.2.3 POLYSCIENCES INC.
17.2.4 ABINGDON HEALTH
17.2.5 ORANOXIS INC.
17.2.6 AESKU.GROUP GMBH
17.2.7 BIO GROUP MEDICAL SYSTEM S.R.L.
17.2.8 PHARMACT GMBH
17.2.9 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
17.2.10 BIOPANDA REAGENTS LTD
17.2.11 ARTRON LABORATORIES INC.
18 RESEARCH METHODOLOGY
18.1 RESEARCH DATA
18.1.1 SECONDARY DATA
18.1.1.1 Key data from secondary sources
18.1.2 PRIMARY DATA
18.1.2.1 Primary sources
18.1.2.2 Key industry insights
18.1.2.3 Key data from primary sources
18.1.2.4 Breakdown of primary interviews
18.2 MARKET SIZE ESTIMATION
18.2.1 BOTTOM-UP APPROACH
18.2.1.1 Approach 1: Company revenue estimation approach
18.2.1.2 Approach 2: Presentations of companies and primary interviews
18.2.1.3 Approach 3: Primary interviews
18.2.1.4 Approach 4: Growth Forecast
18.2.1.5 CAGR projections
18.2.2 TOP-DOWN APPROACH
18.3 MARKET BREAKDOWN & DATA TRIANGULATION
18.4 RESEARCH ASSUMPTIONS
18.4.1 STUDY-RELATED ASSUMPTIONS
18.4.2 GROWTH RATE ASSUMPTIONS
18.5 RISK ASSESSMENT
18.6 RESEARCH LIMITATIONS
19 APPENDIX
19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 REAL INCIDENCE OF HIV (2023)
TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2025
TABLE 4 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
TABLE 5 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 7 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 8 EUROPE: MACROECONOMIC INDICATORS
TABLE 9 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 10 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 11 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 12 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 13 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 14 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 15 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 16 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 17 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 19 KEY PATENTS IN LATERAL FLOW ASSAYS, 2022–2026
TABLE 20 KEY COMPANIES IMPLEMENTING AI IN LATERAL FLOW ASSAYS MARKET
TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS, WITH AND WITHOUT ANALYZERS
TABLE 32 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 38 LATERAL FLOW ASSAY READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 39 LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 EUROPE: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 NORTH AMERICA: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 EUROPE: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 ASIA PACIFIC: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 LATIN AMERICA: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 50 NORTH AMERICA: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 EUROPE: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 ASIA PACIFIC: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 LATIN AMERICA: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 55 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 56 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 61 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 73 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 79 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 MAJOR PRODUCTS: DENGUE TESTING
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 111 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 127 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 132 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 142 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 163 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 173 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 175 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 178 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 189 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 190 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 191 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 196 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 200 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/ LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 210 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 211 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 212 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 216 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 217 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 219 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 220 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 221 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 222 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 224 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 226 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 227 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 228 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 229 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 230 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 231 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 232 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 233 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 234 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 235 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 236 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 237 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 238 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 239 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 241 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 242 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 243 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 244 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 245 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 246 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 247 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 248 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 249 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 250 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 251 LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 252 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 253 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 255 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 256 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 257 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2024–2031 (USD MILLION)
TABLE 258 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 259 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 260 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 261 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 262 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 263 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 265 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 267 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 268 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 269 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 270 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 272 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 273 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 274 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 275 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 276 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 277 LATERAL FLOW ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 280 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 288 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 289 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 290 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 291 US: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 295 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 299 US: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 300 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 302 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 306 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 310 CANADA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 311 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 312 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 314 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 1 LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 REAL INCIDENCE OF HIV (2023)
TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2025
TABLE 4 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
TABLE 5 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030
TABLE 7 NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 8 EUROPE: MACROECONOMIC INDICATORS
TABLE 9 ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 10 LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 11 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 12 LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 13 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY PRODUCTS, BY REGION, 2024–2026 (USD)
TABLE 14 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY PRODUCTS, BY KEY PLAYER, 2024–2026 (USD)
TABLE 15 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 16 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD MILLION)
TABLE 17 LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 19 KEY PATENTS IN LATERAL FLOW ASSAYS, 2022–2026
TABLE 20 KEY COMPANIES IMPLEMENTING AI IN LATERAL FLOW ASSAYS MARKET
TABLE 21 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 29 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
TABLE 30 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 31 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS, WITH AND WITHOUT ANALYZERS
TABLE 32 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 33 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 LATERAL FLOW READERS OFFERED, BY COMPANY
TABLE 38 LATERAL FLOW ASSAY READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 39 LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 40 NORTH AMERICA: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 EUROPE: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 ASIA PACIFIC: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 LATIN AMERICA: LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 45 NORTH AMERICA: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46 EUROPE: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 ASIA PACIFIC: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 LATIN AMERICA: DIGITAL/HANDHELD LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 50 NORTH AMERICA: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 EUROPE: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 ASIA PACIFIC: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 LATIN AMERICA: BENCHTOP LATERAL FLOW ASSAY READERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 55 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 56 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 61 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY REGION, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 71 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 73 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 79 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 MAJOR PRODUCTS: DENGUE TESTING
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 85 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 89 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION, 2024–2031 (USD MILLION)
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 100 LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 102 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 109 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 111 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY REGION, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 114 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 116 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118 EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 120 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 122 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 124 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 125 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 126 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 127 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 129 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 130 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 131 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 132 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 134 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 135 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 136 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY REGION, 2024–2031 (USD MILLION)
TABLE 137 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 138 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 139 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 140 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 141 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY REGION, 2024–2031 (USD MILLION)
TABLE 142 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 143 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 144 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 145 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 148 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 150 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 151 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 152 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 153 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 156 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 158 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 161 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 162 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 163 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 165 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 166 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 167 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 168 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 169 EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 170 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 172 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 173 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 174 EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 175 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 176 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 177 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 178 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 179 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 180 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 181 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 182 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 184 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 185 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 186 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 187 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 188 KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 189 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 190 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 191 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 192 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 193 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 194 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 195 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 196 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 197 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 198 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 199 KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE
TABLE 200 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 201 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/ LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 202 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 203 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 204 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 205 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 206 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 207 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 208 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 209 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 210 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY REGION, 2024–2031 (USD MILLION)
TABLE 211 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 212 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 214 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 215 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 216 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 217 EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 218 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 219 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 220 LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 221 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 222 EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 224 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 225 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2024–2031 (USD MILLION)
TABLE 226 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 227 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 228 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 229 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 230 LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 231 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 232 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 233 EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 234 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 235 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 236 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 237 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 238 EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 239 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 240 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 241 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 242 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 243 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 244 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 245 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 246 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY REGION, 2024–2031 (USD MILLION)
TABLE 247 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 248 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 249 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 250 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 251 LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 252 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 253 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 254 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 255 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 256 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 257 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY REGION, 2024–2031 (USD MILLION)
TABLE 258 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 259 EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 260 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 261 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 262 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 263 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 264 EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 265 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 267 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 268 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 269 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 270 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 272 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 273 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 274 EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 275 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 276 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 277 LATERAL FLOW ASSAYS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 278 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 279 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 280 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 282 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 284 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 288 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 289 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 290 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 291 US: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 293 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 294 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 295 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 299 US: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 300 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 302 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 304 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 306 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 309 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2024–2031 (USD MILLION)
TABLE 310 CANADA: LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2024–2031 (USD MILLION)
TABLE 311 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 312 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 313 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 314 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 316 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2024–2031 (USD MILLION)
TABLE 318 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 2 GLOBAL LATERAL FLOW ASSAYS MARKET, 2024–2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2023–2026
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF LATERAL FLOW ASSAYS MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN LATERAL FLOW ASSAYS MARKET, 2025
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 7 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
FIGURE 8 KITS & REAGENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 9 CLINICAL TESTING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 10 SANDWICH ASSAYS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 BLOOD SAMPLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 HOSPITALS & CLINICS SEGMENT TO COMMAND LARGEST SHARE DURING FORECAST PERIOD
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS
FIGURE 19 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN LATERAL FLOW ASSAYS MARKET
FIGURE 21 PATENT ANALYSIS FOR LATERAL FLOW ASSAYS, JANUARY 2016–DECEMBER 2025
FIGURE 22 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
FIGURE 25 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2023–2025
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET (2025)
FIGURE 29 EV/EBITDA OF KEY VENDORS, 2025
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 31 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 32 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT
FIGURE 34 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2025
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 39 SIEMENS AG: COMPANY SNAPSHOT (2025)
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2025)
FIGURE 41 BIOM?RIEUX SA: COMPANY SNAPSHOT (2025)
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 REVVITY, INC.: COMPANY SNAPSHOT (2025)
FIGURE 44 QIAGEN N.V.: COMPANY SNAPSHOT (2025)
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 46 HOLOGIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 47 ORASURE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN
FIGURE 49 KEY DATA FROM SECONDARY SOURCES
FIGURE 50 LIST OF PRIMARY SOURCES
FIGURE 51 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 53 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 55 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 56 DATA TRIANGULATION METHODOLOGY
FIGURE 57 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT
FIGURE 1 KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 2 GLOBAL LATERAL FLOW ASSAYS MARKET, 2024–2031
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2023–2026
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF LATERAL FLOW ASSAYS MARKET
FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN LATERAL FLOW ASSAYS MARKET, 2025
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 7 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
FIGURE 8 KITS & REAGENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 9 CLINICAL TESTING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 10 SANDWICH ASSAYS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 11 BLOOD SAMPLES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
FIGURE 12 HOSPITALS & CLINICS SEGMENT TO COMMAND LARGEST SHARE DURING FORECAST PERIOD
FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 14 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16 LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS
FIGURE 19 LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN LATERAL FLOW ASSAYS MARKET
FIGURE 21 PATENT ANALYSIS FOR LATERAL FLOW ASSAYS, JANUARY 2016–DECEMBER 2025
FIGURE 22 MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
FIGURE 25 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2023–2025
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET (2025)
FIGURE 29 EV/EBITDA OF KEY VENDORS, 2025
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 31 LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON
FIGURE 32 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT
FIGURE 34 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2025
FIGURE 36 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 39 SIEMENS AG: COMPANY SNAPSHOT (2025)
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2025)
FIGURE 41 BIOM?RIEUX SA: COMPANY SNAPSHOT (2025)
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 REVVITY, INC.: COMPANY SNAPSHOT (2025)
FIGURE 44 QIAGEN N.V.: COMPANY SNAPSHOT (2025)
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 46 HOLOGIC, INC.: COMPANY SNAPSHOT (2025)
FIGURE 47 ORASURE TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 48 LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN
FIGURE 49 KEY DATA FROM SECONDARY SOURCES
FIGURE 50 LIST OF PRIMARY SOURCES
FIGURE 51 KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 53 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 55 LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 56 DATA TRIANGULATION METHODOLOGY
FIGURE 57 LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT
More Publications
Cardiac Marker Testing Market by Product, Biomarker (Troponin, CK-MB, BNP, hs-CRP, Myoglobin), Technology (Chemiluminescence, ELISA), Indication (MI, CHF, Atherosclerosis), Assay Format (Singleplex, Multiplex), Point of Testing - Global Forecast to 2031
US$ 2,970.00
June 2026
372 pages
In Vitro Fertilization Market Size, Share & Trends by Product (Equipment, Reagent, Accessories), Equipment (Imaging, Incubator, Microscope, Micromanipulator), Procedure (Conventional, ICSI, donor), Cycle (Fresh, Frozen), End-user (Hospital, Clinic) - Global Forecast to 2029
US$ 2,970.00
August 2024
281 pages
U.S. In Vitro Diagnostics (IVD) Market by Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology), Application (Infectious Diseases, Diabetes, Cancer, Cardiology), End User (Hospitals & Laboratories) & by Region - Forecast to 2020
US$ 7,200.00
March 2016
179 pages
